Skip to main content
. 2023 Nov 20;15(22):4847. doi: 10.3390/nu15224847

Table 4.

Ulcerative Colitis pre- and post-vedolizumab clinical, endoscopic, and laboratory values.

Pre-Vedolizumab Post-Vedolizumab p
UC Activity Index 6.0 [2.3, 8.0] 1.0 [0.0, 2.5] <0.001
CRP (mg/dL) 3.2 [0.9, 11.3] 2.5 [1.1, 6.7] 0.777
ESR (mm/h) 11.0 [6.0, 27.0] 7.5 [2.0, 16.8] 0.245
Fecal Calprotectin (μg/mg) 1250.0 [299.0, 1250.0] 196.0 [52.0, 2000.0] 0.479
Fecal Lactoferrin (μg/g) 130.9 [50.9, 276.1] 49.0 [28.2, 81.1] 0.134
UCEIS 6.0 [3.0, 8.8] 1.0 [0.0, 5.0] <0.001
BMI (kg/m2) 24.4 [21.3, 28.7] 25.87 [23.1, 29.9] 0.337
Vitamin D (ng/mL) 33.2 [25.0, 38.8] 45.0 [29.5, 60.0] 0.008
Albumin (g/dL) 3.9 [3.0, 4.1] 3.9 [3.6, 4.2] 0.484
Iron (umol/L) 65.0 [34.0, 101.0] 83.0 [52.3, 102.3] 0.423
TIBC (μg/dL) 322.0 [283.5, 361.8] 324.5 [295.0 353.0] 0.563
Ferritin (μg/L) 54.5 [23.3, 135.0] 55.0 [26.0, 122.0] 0.766
Iron Sat (%) 27.0 [12.8, 29.0] 25.5 [16.8, 32.3] 0.477
Vitamin B12 (pg/mL) 619.0 [404.8, 840.8] 548.0 [440.0, 687.0] 0.637
Folate (ng/mL) 12.5 [10.7, 15.4] 11.3 [9.2, 19.9] 0.942
Zinc (μg/dL) (mean (SD)) 77.4 (19.6) 79.9 (8.8) 0.741

Statistically significant findings noted in bold.